Astellas Eyes Ophthalmic Build-Up Through Japan Alliance
This article was originally published in PharmAsia News
Executive Summary
Astellas has again signaled its increasing interest in the ophthalmology area through a deal with a small Japanese start-up for global rights to a gene therapy for retinitis pigmentosa.